Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 20, Pages 1965-1966Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2106075
Keywords
-
Categories
Ask authors/readers for more resources
The manufacturer responds to recent reports of thrombosis and severe thrombocytopenia in recipients of the Ad26.COV2.S vaccine.
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Manufacturer's Response The manufacturer of the Ad26.COV2.S vaccine against Covid-19 comments on recent reports of thrombosis, including cerebral venous sinus thrombosis, associated with severe thrombocytopenia in several recipients of the vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
